PureTech Health Valuation
| PRTC Stock | 140.20 1.20 0.85% |
At this time, the company appears to be overvalued. PureTech Health plc holds a recent Real Value of USD131.79 per share. The prevailing price of the company is USD140.2. Our model determines the value of PureTech Health plc from analyzing the company fundamentals such as Current Valuation of (39.38 M), shares owned by insiders of 15.72 %, and Return On Equity of -0.22 as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.3557 | Enterprise Value -39.4 M | Enterprise Value Ebitda (9.30) | Price Sales 720.2835 | Enterprise Value Revenue 348.8244 |
Overvalued
Today
Please note that PureTech Health's price fluctuation is very steady at this time. Calculation of the real value of PureTech Health plc is based on 3 months time horizon. Increasing PureTech Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PureTech stock is determined by what a typical buyer is willing to pay for full or partial control of PureTech Health plc. Since PureTech Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PureTech Stock. However, PureTech Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 140.2 | Real 131.79 | Hype 141.98 | Naive 136.19 |
The intrinsic value of PureTech Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PureTech Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PureTech Health plc helps investors to forecast how PureTech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PureTech Health more accurately as focusing exclusively on PureTech Health's fundamentals will not take into account other important factors: PureTech Health Cash |
|
PureTech Health Total Value Analysis
PureTech Health plc is at this time projected to have takeover price of (39.38 M) with market capitalization of 337.09 M, debt of 25.34 M, and cash on hands of . The negative valuation of PureTech Health may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the PureTech Health fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(39.38 M) | 337.09 M | 25.34 M |
PureTech Health Investor Information
About 16.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PureTech Health plc recorded a loss per share of 0.24. The entity had not issued any dividends in recent years. PureTech Health plc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.PureTech Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PureTech Health has an asset utilization ratio of 0.11 percent. This implies that the Company is making USD0.001081 for each dollar of assets. An increasing asset utilization means that PureTech Health plc is more efficient with each dollar of assets it utilizes for everyday operations.PureTech Health Ownership Allocation
PureTech Health owns a total of 239.42 Million outstanding shares. The majority of PureTech Health plc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PureTech Health plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PureTech Health. Please pay attention to any change in the institutional holdings of PureTech Health plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PureTech Health Profitability Analysis
The company reported the revenue of 750 K. Net Loss for the year was (66.63 M) with loss before overhead, payroll, taxes, and interest of (81.55 M).About PureTech Health Valuation
The stock valuation mechanism determines PureTech Health's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of PureTech Health plc based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of PureTech Health. We calculate exposure to PureTech Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PureTech Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -85.9 M | -81.6 M |
Additional Tools for PureTech Stock Analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.